[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dianthus Therapeutics Inc (DNTH)

Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)

NEW YORK and WALTHAM, Mass., July 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to...

DNTH : 98.64 (+1.07%)
Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...

DNTH : 98.64 (+1.07%)
Stocks Settle Sharply Lower on Escalating Middle East Tensions

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.62%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.87%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.98%. June...

ALK : 46.80 (-5.30%)
GOOGL : 352.51 (-1.31%)
MPC : 296.88 (+4.63%)
AAPL : 317.31 (+0.63%)
FDXF : 148.37 (-0.78%)
TSLA : 394.76 (-3.19%)
FANG : 191.60 (+4.48%)
STX : 860.66 (-5.46%)
WDC : 555.55 (-4.64%)
AMD : 534.39 (-4.21%)
SPY : 749.17 (-0.77%)
META : 656.73 (-1.86%)
Stocks Resume Decline as Chipmakers and AI Companies Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.61%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.80%. June E-mini S&P futures...

ALK : 46.80 (-5.30%)
MPC : 296.88 (+4.63%)
FDXF : 148.37 (-0.78%)
FANG : 191.60 (+4.48%)
WDC : 555.55 (-4.64%)
AMD : 534.39 (-4.21%)
SPY : 749.17 (-0.77%)
ILMN : 190.05 (-0.08%)
SMMT : 15.30 (+0.33%)
MU : 937.00 (-4.32%)
AAL : 16.31 (-3.78%)
QQQ : 711.74 (-1.90%)
Stocks Fall on Weakness in Tech and Trucking Companies

The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.28%. June E-mini S&P futures...

SAIA : 432.06 (+2.67%)
ALK : 46.80 (-5.30%)
UAL : 121.16 (-3.84%)
MPC : 296.88 (+4.63%)
AVGO : 384.05 (-3.98%)
CVX : 182.20 (+3.29%)
HNGE : 90.00 (+1.35%)
CBRL : 52.35 (+3.83%)
FDXF : 148.37 (-0.78%)
$IUXX : 29,264.10 (-1.88%)
ARCB : 149.50 (+1.61%)
ZNU26 : 108-190 (-0.10%)
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to...

DNTH : 98.64 (+1.07%)
Dianthus Therapeutics to Participate in Two Investor Conferences

NEW YORK and WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform...

DNTH : 98.64 (+1.07%)
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results

Early GO decision reached in CAPTIVATE in March 2026 based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A  Claseprubart granted...

DNTH : 98.64 (+1.07%)
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and WALTHAM, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform...

DNTH : 98.64 (+1.07%)
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and WALTHAM, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to...

DNTH : 98.64 (+1.07%)

Barchart Exclusives

Costco vs. Walmart: 1 Dividend-Paying Retail Giant Stands Above the Other
While both Costco and Walmart are exceptional companies with long-lasting competitive advantages, one offers a better investment case. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.